Israeli migraine treatment co Theranica raises $45m

Nerivio is an FDA-cleared, prescribed, smartphone-controlled, drug-free wearable device for the treatment of episodic and chronic migraine in people aged 12 and older.

Related Keywords

United States ,Israel ,Americans ,Israeli ,Shimon Eckhouse ,Ronen Jashek ,Slava Barabash , ,New Rhein Healthcare Investors ,Lightspeed Venture Partners ,Takoa Invest ,Corundum Open ,